The telegram was sent by the foreign ministry to Fabián Salvioli, special rapporteur on the promotion of truth, justice, reparation and guarantees of non-recurrence, after he criticised government plans to commemorate the 1964 coup, the BBC said.
Pablo de Greiff was appointed by the UN Human Rights Council to serve as the first Special Rapporteur on the promotion of truth, justice, reparation, and guarantees of non-recurrence in 2012.
Specifically, her work has been referenced by several United Nations special units, including the Special Rapporteur on the Promotion of Truth, Justice, Reparation, and Guarantees of Non-Recurrence, and the Working Group on Forced Disappearances.
We selected patients with the following inclusion criteria: invasive ductal carcinoma, in cases of non-recurrence, patients had been followed-up for a minimum of 5 years of follow-up.
In a meta-analysis by Kee et al., the pooled relative risk of ATT for improvement in inflammation related to TBU was only 1.17 (95% CI 0.74 1.85) and 1.42 (95% CI 1.24 1.63) for non-recurrence of inflammation.
1 year post-KT elevated concentrations are observed in patients with recurrence of FSGS compared to non-recurrence in patients.
However, although the possibility of selection bas, recurrence to non-recurrence ratio showed the increasing trend of recurrence rate as the stage get advanced in the patients with discordant findings (Table 5).
Disease-free survival was defined as the time from randomisation to the date of first disease recurrence, or for non-recurrence, death; censoring was at longest follow-up.
In the liver of patients with non-recurrence, expression of PDGFC and other angiogenesis genes, cancer stem cell marker genes, and genes related to tumor progression was down-regulated, while expression of genes related to hepatocyte differentiation, tumor suppression genes, and other genes related to apoptosis induction was up-regulated.
Of these, carcinoembryonic antigen (CEA) is the most commonly used tumor marker for the detection of non-symptomatic recurrence.
Two recent publications have shown an increased risk of non-invasive recurrence in HER2+ tumours [ 8, 17].
